Acadia Healthcare Net Worth
Acadia Healthcare Net Worth Breakdown | ACHC |
Acadia Healthcare Net Worth Analysis
Acadia Healthcare's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Acadia Healthcare's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Acadia Healthcare's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Acadia Healthcare's net worth analysis. One common approach is to calculate Acadia Healthcare's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Acadia Healthcare's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Acadia Healthcare's net worth. This approach calculates the present value of Acadia Healthcare's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Acadia Healthcare's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Acadia Healthcare's net worth. This involves comparing Acadia Healthcare's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Acadia Healthcare's net worth relative to its peers.
To determine if Acadia Healthcare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Acadia Healthcare's net worth research are outlined below:
| Acadia Healthcare generated a negative expected return over the last 90 days | |
| Acadia Healthcare has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 2.93 B. Net Loss for the year was (21.67 M) with profit before overhead, payroll, taxes, and interest of 1.12 B. | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Disposition of 2025 shares by Khan Nasser of Acadia Healthcare at 72.51 subject to Rule 16b-3 |
Acadia Healthcare Quarterly Good Will |
|
Acadia Healthcare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Acadia Healthcare. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Acadia Healthcare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Acadia Healthcare's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Acadia Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Acadia Healthcare backward and forwards among themselves. Acadia Healthcare's institutional investor refers to the entity that pools money to purchase Acadia Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Citadel Advisors Llc | 2024-09-30 | 2.2 M | Amvescap Plc. | 2024-06-30 | 1.8 M | Fmr Inc | 2024-09-30 | 1.7 M | Geode Capital Management, Llc | 2024-09-30 | 1.6 M | P2 Capital Partners, Llc | 2024-09-30 | 1.6 M | Bank Of New York Mellon Corp | 2024-06-30 | 1.2 M | Alyeska Investment Group, L.p. | 2024-09-30 | 1.2 M | Stephens Inv Mgmt Group Llc | 2024-09-30 | 1.2 M | Rock Springs Capital Management Lp | 2024-06-30 | 1.2 M | Wellington Management Company Llp | 2024-06-30 | 10.4 M | Vanguard Group Inc | 2024-09-30 | 8.9 M |
Follow Acadia Healthcare's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.55 B.Market Cap |
|
Project Acadia Healthcare's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | 0.11 | 0.06 | |
| Return On Equity | (0.01) | (0.01) |
When accessing Acadia Healthcare's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Acadia Healthcare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Acadia Healthcare's profitability and make more informed investment decisions.
Please note, the presentation of Acadia Healthcare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Acadia Healthcare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Acadia Healthcare's management manipulating its earnings.
Evaluate Acadia Healthcare's management efficiency
Acadia Healthcare has return on total asset (ROA) of 0.0606 % which means that it generated a profit of $0.0606 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0976 %, meaning that it created $0.0976 on every $100 dollars invested by stockholders. Acadia Healthcare's management efficiency ratios could be used to measure how well Acadia Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.0067. In addition to that, Return On Capital Employed is expected to decline to 0.06. At present, Acadia Healthcare's Intangibles To Total Assets are projected to slightly decrease based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.51, whereas Total Assets are forecasted to decline to about 4.4 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 31.75 | 17.96 | |
| Tangible Book Value Per Share | 6.47 | 6.79 | |
| Enterprise Value Over EBITDA | 44.86 | 47.10 | |
| Price Book Value Ratio | 2.54 | 2.50 | |
| Enterprise Value Multiple | 44.86 | 47.10 | |
| Price Fair Value | 2.54 | 2.50 |
Examining the leadership quality of Acadia Healthcare offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue 1.7547 | Revenue 3.1 B | Quarterly Revenue Growth 0.087 | Revenue Per Share 34.13 | Return On Equity 0.0976 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Acadia Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Acadia Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Acadia Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Acadia Healthcare Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
10Q | 30th of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 27th of September 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 29th of July 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Acadia Healthcare Earnings per Share Projection vs Actual
Acadia Healthcare Corporate Management
| Laura Groschen | Chief Officer | Profile | |
| Heather CPA | Chief Officer | Profile | |
| Laurence Harrod | Ex Fin | Profile | |
| Mark Palmenter | Chief Officer | Profile | |
| Isa Diaz | Senior Affairs | Profile |
Already Invested in Acadia Healthcare?
The danger of trading Acadia Healthcare is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Acadia Healthcare is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Acadia Healthcare. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Acadia Healthcare is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Acadia Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Acadia Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Acadia Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Acadia Healthcare Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acadia Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade Acadia Stock refer to our How to Trade Acadia Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acadia Healthcare. If investors know Acadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acadia Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.076 | Earnings Share 3.05 | Revenue Per Share 34.13 | Quarterly Revenue Growth 0.087 | Return On Assets 0.0606 |
The market value of Acadia Healthcare is measured differently than its book value, which is the value of Acadia that is recorded on the company's balance sheet. Investors also form their own opinion of Acadia Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Acadia Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acadia Healthcare's market value can be influenced by many factors that don't directly affect Acadia Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acadia Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Acadia Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acadia Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.